166Ho (T1/2 ≈ 26.8 h) is an emerging theragnostic radionuclide of interest in nuclear medicine due to its peculiar decay scheme, featuring high-energy β− emission (≈ 1.8 MeV) coupled with the main gamma-ray emission (≈ 80.6 keV). Using the new 166Ho activity standard and the well-calibrated, high-energy resolution HPGe detector, both available at ENEA-INMRI, a new determination of several 166Ho gamma-ray emission intensities, Iγ, was performed with low uncertainty. The new Iγ values contributed to the Decay Data Evaluation Project.

Measurements of the absolute gamma-ray emission intensities from the decay of 166Ho

Capogni M.;Fazio A.;De Felice P.
2024-01-01

Abstract

166Ho (T1/2 ≈ 26.8 h) is an emerging theragnostic radionuclide of interest in nuclear medicine due to its peculiar decay scheme, featuring high-energy β− emission (≈ 1.8 MeV) coupled with the main gamma-ray emission (≈ 80.6 keV). Using the new 166Ho activity standard and the well-calibrated, high-energy resolution HPGe detector, both available at ENEA-INMRI, a new determination of several 166Ho gamma-ray emission intensities, Iγ, was performed with low uncertainty. The new Iγ values contributed to the Decay Data Evaluation Project.
2024
166Ho
Gamma-ray emission intensities
Gamma-ray spectrometry
TDCR
File in questo prodotto:
File Dimensione Formato  
Measurements of the absolute gamma-ray emission intensities from the decay of 166Ho.pdf

accesso aperto

Tipologia: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 1.67 MB
Formato Adobe PDF
1.67 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.12079/81972
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
social impact